Does GLOFITAMAB Cause Cytokine release syndrome? 415 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 415 reports of Cytokine release syndrome have been filed in association with GLOFITAMAB (Columvi). This represents 37.2% of all adverse event reports for GLOFITAMAB.
415
Reports of Cytokine release syndrome with GLOFITAMAB
37.2%
of all GLOFITAMAB reports
102
Deaths
239
Hospitalizations
How Dangerous Is Cytokine release syndrome From GLOFITAMAB?
Of the 415 reports, 102 (24.6%) resulted in death, 239 (57.6%) required hospitalization, and 17 (4.1%) were considered life-threatening.
Is Cytokine release syndrome Listed in the Official Label?
Yes, Cytokine release syndrome is listed as a known adverse reaction in the official FDA drug label for GLOFITAMAB.
What Other Side Effects Does GLOFITAMAB Cause?
Disease progression (183)
Off label use (129)
Death (125)
Neutropenia (109)
Pyrexia (78)
Febrile neutropenia (69)
Covid-19 (62)
Drug ineffective (53)
Immune effector cell-associated neurotoxicity syndrome (45)
Infection (44)
What Other Drugs Cause Cytokine release syndrome?
AXICABTAGENE CILOLEUCEL (4,140)
CYCLOPHOSPHAMIDE (2,263)
TISAGENLECLEUCEL (1,660)
FLUDARABINE (1,458)
RITUXIMAB (1,404)
BLINATUMOMAB (952)
DEXAMETHASONE (853)
DOXORUBICIN (850)
BREXUCABTAGENE AUTOLEUCEL (827)
VINCRISTINE (771)
Which GLOFITAMAB Alternatives Have Lower Cytokine release syndrome Risk?
GLOFITAMAB vs GLOFITAMAB-GXBM
GLOFITAMAB vs GLUCAGON
GLOFITAMAB vs GLUCAGON\GLUCAGON\WATER
GLOFITAMAB vs GLUCARPIDASE
GLOFITAMAB vs GLUCOPHAGE